J. Goldman & CO LP Iovance Biotherapeutics, Inc. Put Options Transaction History

J. Goldman & CO LP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$7.59 - $17.47 $204,930 - $471,689	27,000 New	27,000 $400,000
Q3 2023 Nov 14, 2023	BUY	$4.44 - $8.79 $239,760 - $474,659	54,000 New	54,000 $245,000
Q1 2023 May 15, 2023	BUY	$5.53 - $8.22 $2.24 Million - $3.33 Million	405,000 New	405,000 $2.47 Million
Q1 2021 May 17, 2021	SELL	$28.67 - $52.59 $516,060 - $946,620	-18,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$28.04 - $50.26 $504,720 - $904,680	18,000 New	18,000 $835,000
Q2 2020 Aug 14, 2020	SELL	$27.21 - $41.0 $1.36 Million - $2.05 Million	-50,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$19.54 - $38.85 $977,000 - $1.94 Million	50,000 New	50,000 $1.5 Million

312

237M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.18B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.